¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fibrinogen-fibrin conversion syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® conversion ÇÑ±Û Àüȯ
¼³¸í   
  1. ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °Í. 2. ¾î¶² º´À̳ª ¹ÝÀÀÀÌ ÇÑ »óÅ¿¡¼­ ´Ù¸¥ »óÅ·Πº¯Çϴ °Í.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
¿µ¹® testicular feminization syndrome ÇÑ±Û °íȯ¿©¼ºÈ­ÁõÈıº
¼³¸í   
  ÀÌÂ÷¼ºÀåÀ» Æ÷ÇÔÇÏ¿©, ¿Ü¼º±âÀÇ ¹ßÀ°Àº ¿©¼ºÀÌÁö¸¸ °íȯÀÌ Á¸ÀçÇϰí, Àڱðú ÀڱðüÀÌ °áÇ̵Ǿî Àִ ³²¼º °ÅÁþ³²³àÇѸöÁõÀÇ ±Ø´ÜÀû ÇüÅÂÀÌ´Ù. À̰ÍÀº Å×½ºÅ佺Å×·ÐÀÇ ÀÛ¿ë¿¡ ´ëÇÑ ¸»´Ü±â°üÀÇ ÀúÇ׿¡ ±âÀÎÇÑ´Ù.
  
  
¿µ¹® irritable bowel syndrome ÇÑ±Û °ú¹Î¼º´ëÀåÁõÈıº
¼³¸í   
  ¹èº¯Àå¾Ö, º¹Åë, º¹ºÎÆØ¸¸ µîÀÇ Áõ»óÀÌ ÀÖÀ¸³ª ±âÁúÀûÀΠº´º¯ÀÌ ¾øÀ½ÀÌ È®ÀεȠ¿¹¸¦ ÃѸÁ¶óÇÑ ÀÓ»ó ÁõÈıºÀÌ´Ù. °¡Àå ÈçÇÑ ¼ÒÈ­±â ÁúȯÀ̸ç(Àü¼ÒÈ­±â È¯ÀÚÀÇ 70~80%) °¡Àå ÈçÇÑ Áúº´(Àüü Àα¸ÀÇ ¾à 20%)ÀÌ´Ù. ¿©¼ºÀÌ ³²¼º¿¡ ºñÇØ 2¹è Á¤µµ ¸¹ÀÌ ¹ß»ýÇϸç 30´ë ¹× 40´ë¿¡¼­ È£¹ßÇÏ°í ¼±Áø °ø¾÷±¹¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. Áø´ÜÀ» À§Çؼ­´Â º´·Â Ã»Ãë°¡ °¡Àå Áß¿äÇ졒ʡ¢Á¾ °Ë»ç·Î¼­ ±âÁúº´À» Á¦¿ÜÇØ¾ß ÇÑ´Ù. Ä¡·á·Î´Â ¾ÈÁ¤¿ä¹ý(Á¤½Å°úÀû ¸é´ã ¹× ½É¸®¿ä¹ý, ½Å°æ¾ÈÁ¤Á¦), ½Ä»ç¿ä¹ý(°í¼¶À¯Áú À½½Ä ¼·Ãë, Àڱؼº À½½Ä ÇÇÇϱâ), ¾à¹° ¿ä¹ý(âÀÚ°æ·Ã ÁøÁ¤Á¦, º¯ºñ ¿ÏÈ­Á¦, Áö»çÁ¦) µîÀ» »ç¿ëÇÑ´Ù.
¿µ¹® withdrawal syndrome ÇÑ±Û ±Ý´ÜÁõÈıÙ
¼³¸í   
  ¾ËÄÚ¿Ã, ¸¶¾à, ¹ÙºñÅõ¸£»ê°è ÃÖ¸é¾à µîÀÇ ¾à¹°À» Àå±â°£ º¹¿ëÇÏ¿© ¾à¹°ÀÌ ¾øÀ̴ °ßµô ¼ö ¾ø°ÔµÈ µÚ, ±× ¾à¹°À» ÁßÁöÇÑ °æ¿ì¿¡ ³ªÅ¸³ª´Â, °íÅëÀÌ ¼ö¹ÝµÇ´Â ½ÅüÀû Áõ»óÀ» ¸»ÇÑ´Ù. ¿¬¼Ó º¹¿ëÀÇ ±â°£¿¡ µû¶ó Áõ»óÀÌ ¹«°Å¿öÁø´Ù. Åë»óÀûÀ¸·Î ±¸Åä, ¼³»ç, Ç÷¾Ð»ó½Â, ºü¸¥¸Æ, ¶¡³², È¥¼ö µîÀÇ Áõ»óÀÌ ³ªÅ¸³­´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • conversion disorder
    ÀüȯÀå¾Ö
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • digital scan conversion
    µðÁöÅнºÄµÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • hysterical conversion
    È÷½ºÅ׸®Àüȯ
  • internal conversion
    ³»ºÎº¯È¯
  • positive conversion
    ¾ç¼ºÀüȯ
  • peripheral conversion
    ¸»ÃÊÀüȯ
  • roentgen-to-rad conversion factor
    ·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ
  • peripheral conversion
    ¸»ÃÊÀüȯ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • acquired immunodeficiency syndrome
    (¢¡AIDS) ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • syndrome of inappropriate antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • syndrome
    ÁõÈıº
  • adrenogenital syndrome
    ºÎ½Å¼º±âÁõÈıº
  • afferent loop syndrome
    µéâÀÚÁõÈıº
  • Alport syndrome
    ¾ËÆ÷Æ®ÁõÈıº
  • Asherman's syndrome
    (¢¡ intrauterine synechia) ¾Æ¼Å¸¸ÁõÈıº
  • carpal tunnel syndrome
    ¼Õ¸ñ±¼ÁõÈıº, ¼ö±Ù°üÁõÈıº
  • cauda equina syndrome
    ¸»ÃÑÁõÈıº, ¸¶¹ÌÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • contact urticaria syndrome
    Á¢Ã˵ε巯±âÁõÈıº
  • cubital tunnel syndrome
    ÆÈ²ß±¼ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • congenital conversion nipple
    ¼±ÃµÀüȯÀ¯µÎ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • gene conversion
    À¯ÀüÀÚº¯È¯
  • hysterical conversion
    È÷½ºÅ׸®Àüȯ
  • internal conversion
    ³»ºÎº¯È¯
  • lysogenic conversion
    ¿ë¿øÀüȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SPCA= serum prothrombin conversion a
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüÈ­ÃËÁø¼Ò.
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • gene conversion
    À¯ÀüÀÚº¯È¯.
  • gene conversion
    À¯ÀüÀÚº¯È¯(ܨüµ).
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ.
  • hysterical conversion
    ÀüȯÈ÷½ºÅ׸®,È÷½ºÅ׸®Àüȯ(¡­ï®üµ)
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • positive conversion
    ¾çÀü(È­)
  • Browns syndrome->superior oblique tendon sheath syndrome
    ºê¶ó¿îÁõÈıº
  • Cowdens syndrome = multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
  • ICE syndrome=iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • Lowes syndrome->oculocerebrorenal syndrome
    ·Î¿ìÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ(ï®üµ).
  • conversion disorder
    ÀüȯÀå¾Ö(ï®üµî¡äô)., Àüȯº´
  • conversion factor
    º¯È¯ ÀÎÀÚ
  • conversion heat
    Àüȯ¿­(ï®üµæð).
  • conversion neurosis
    Àüȯ½Å°æÁõ(ï®üµ ãêÌèñø)., Àüȯ½Å°æº´
  • conversion rate
    ÀüȯÀ²(ï®üµëÒ).
  • conversion rate
    ÀüȯÀ²(ËøÌ·Ëô).
  • conversion reaction
    Àüȯ¹ÝÀÀ(ï®üµÚãëë).
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • conversion, lysogenic
    ¿ë¿ø¼ºÀüȯ
  • conversion, phage
    ÆÄÁöÀüȯ
  • digital scan conversion
    ¼ýÀÚ ½ºÄµ º¯È¯ (ܨüµ)
  • digital scan conversion
    µðÁöÅÐ ½ºÄµ º¯È¯
  • direct conversion x-ray detector
    Á÷Á¢ º¯È¯ X¼± °ËÃâ±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Metabolic defect of steroid (Adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
    [¿¾ ¿ë¾î] ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
  • Syndrome
    ÁõÈıº
    [¿¾ ¿ë¾î] ÁõÈÄ
  • Syndrome (Down)
    ÁõÈıº (´Ù¿îÁõÈıº)
    [¿¾ ¿ë¾î] ÁõÈÄ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • Loeffler's syndrome
    ·ÚÇ÷¯ÁõÈıº
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Crigler-Najjar syndrome
    Å©¸®±Û·¯-³ª¾ß¸£ ÁõÈıº(ñøý¦ÏØ)
  • Down's syndrome
    ´Ù¿î ÁõÈıº(ñøý¦ÏØ) (ÔÒ) mongolism
  • ectopic hormone syndrome
    À̼Ò(ì¶á¶) È£¸£¸ó ÁõÈıº(ñøý¦ÏØ)
  • Fanconi's syndrome
    ÆÇÄÚ´Ï ÁõÈıº(ñøý¦ÏØ)
  • fragile X syndrome
    Ãë¾à(öªå°) X ÁõÈıº(ñøý¦ÏØ)
  • general adaptation syndrome
    ÀÏ¹Ý ÀûÀÀ ÁõÈıº(ìéÚõ îêëëñøý¦ÏØ)
  • Hunter's syndrome
    ÇåÅÍ ÁõÈıº(ñøý¦ÏØ)
  • Hurler's syndrome
    Çæ·¯ ÁõÈıº(ñøý¦ÏØ)
  • Lesch-Nyhan syndrome
    ·¹½¬-´ÏÇÑ ÁõÈıº(ñøý¦ÏØ)
  • Pendred's syndrome
    Ææµå·¹µå ÁõÈıº(ñøý¦ÏØ)
  • phytanic acid storage syndrome
    ÇÇź»ê(ß«) ÃàÀû ÁõÈıº(õëîÝñøý¦ÏØ)
  • Sanfillipo's syndrome
    ¼¾Çʸ®Æ÷ ÁõÈıº(ñøý¦ÏØ)
  • simian acquired immune deficiency syndrome
    ¿ø¼þÀÌ ÈÄõ¼º¸é¿ª°áÇÌÁúȯ(ý­ô¸àõØóæ¹ÌÀù¹òðü´)
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å-¿¤¸®½¼ ÁõÈÄ(ñøý¦)
  • antigenic conversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ, º¯È¯, º¯Á¶, ÀüÈ­
  • conversion factor
    º¯È¯ÀÎÀÚ
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • direct conversion x-ray detector
    Á÷Á¢º¯È¯X¼±°ËÃâ±â
  • Banti's syndrome
    ¹ÝƼÁõÈıº
  • battered child syndrome
    ÇÇÇÐ´ë¾ÆÁõÈıº
  • Behcet's syndrome
    º£Ã¼Æ®ÁõÈıº
  • blind loop syndrome
    ¸Í°èÁ¦ÁõÈıº
  • cauda equina syndrome
    ¸¶¹ÌÁõÈıº
  • cord compression syndrome
    ô¼ö¾Ð¹ÚÁõÈıº
  • Cushing's syndrome
    Äí½ÌÁõÈıº
  • double crush syndrome
    ÀÌÁߺмâÁõÈıº
  • empty sella syndrome
    °øÅÍŰ¾ÈÁõÈıº
  • facet syndrome
    ôÃßÈİüÀýÁõÈıº
  • fetal distress syndrome
    žưï¶õÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PPCA plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator
MS Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
PCS palliative care service; Patient Care System; patterns of care study; pelvic congestion syndrome; ph...
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
(14)C Conversion of
1-14C Conversion of
4-14C Conversion of
(14)C conversion of L
DC Degree of conversion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
  • conversion disorder
    Àüȯ Àå¾Ö
    1. ±âÁúÀû ÁúȯÀÌ ¾øÀÌ ¹«ÀǽÄÀûÀÎ ¿ä±¸³ª °¥µîÀ¸·Î ÀÎÇÑ °¨°¢À̳ª ¿îµ¿ ±â´ÉÀÇ Àå¾Ö°¡ Ư¡ÀÎ Á¤½Å Áúȯ. 2. ½Å°æÇÐÀû ¶Ç´Â ³»°úÀû ÁúȯÀÌ ¾øÀÌ ¸¶ºñ, ½Ã·Â »ó½Ç, ÇÔ±¸Áõ
  • conversion factor
    º¯È¯ °è¼ö
  • conversion rate
    ÀüȯÀ²
  • hysteria conversion
    Àüȯ È÷½ºÅ׸®, È÷½ºÅ׸® Àüȯ
    ºÒ¾ÈÀ» ½ÅüÀû ¡ÈÄ ¶Ç´Â Áõ»óÀ¸·Î Àüȯ½ÃÄÑ, ºÒ¾ÈÀ» ¹Ù²Ù¾î ³õ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â È÷½ºÅ׸®.
  • salt water conversion kit
    ¿°·ù º¯È¯ Ŷ
  • A-V syndrome
    A-V ÁõÈıº
  • Aarskog syndrome
    ¾Æ¸£½ºÄÚ±× ÁõÈıº
    À¯Àü¼º ÁõÈıºÀÇ Çϳª·Î X-¿¬°ü¼º ÇüÁú·Î À¯ÀüµÈ´Ù. Ư¡À¸·Î´Â ¾È±¸ °Ý¸®Áõ, ³ÐÀº À­ ÀÔ¼ú, ¼î¿Ã, ÀÛÀº ¼Õ µîÀÌ ÀÖ´Ù. ¾È¸é ¼º±â Çü¼º Àå¾Ö
  • Aase syndrome
    ¾ÆÁî ÁõÈıº
    °æ¹ÌÇÑ ¼ºÀå Áö¿¬, ÀúÇü¼º ºóÇ÷, ´Ù¾çÇÑ ¹éÇ÷±¸ °¨¼ÒÁõ, ¼¼ °³·Î °¥¶óÁø ¾öÁö¹ß°¡¶ô, Á¼Àº ¾î±ú, ´ÊÀº õ¹® Æó¼â, ¾ðûÀÌ, ±¸°³ ÆÄ¿­, ¸Á¸·º´Áõ µîÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ¸·Î¼­ ¿­¼ºÀ¸·Î À¯ÀüµÇ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • abnormal laterality syndrome
    ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıº
    ½ÉÀå¿¡¼­ Á¤»óÀûÀÎ ÁÂ¿ì ´ëĪÀÌ µÚ¹Ù²î°Å³ª ºÒ¿ÏÀüÇÑ °æ¿ì·Î¼­, ÁÂÃøÀ̳ª ¿ìÃøÇüÀ¸·Î ´ëĪÀÎ °æ¿ì°¡ ÀÖ°í À̵鿡¼­ ¿©·¯ °¡Áö ½ÉÀå ±âÇüÀÌ µ¿¹ÝµÇ´Âµ¥ ÀÌ·¯ÇÑ °æ¿ì¸¦ ½ÉÀåÀÇ ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıºÀ̶ó ÇÑ´Ù. À̵é Áúȯ¿¡¼­´Â ½ÉÀå »Ó ¾Æ´Ï¶ó ÁÖ ±â°üÁö¿Í »óÆóµ¿¸ÆÀÇ À§Ä¡ °ü°è ¹× ÆóÀÇ ºÐ¿±, °£°ú ºñÀåÀÇ ÇüÅ ¹× À§Ä¡°¡ ´Þ¶óÁö¸ç ƯÈ÷ ºñÀåÀÌ ¾ø´Â ¹«ºñÁõ
  • absent pulmonary valve syndrome
    Æó µ¿¸Æ ÆÇ °á¿© ÁõÈıº
    ´Üµ¶À¸·Î ÀϾ´Â °æ¿ì´Â ±ØÈ÷ µå¹°¸ç, ½É½Ç Áß°Ý °á¼Õ, ¿ì½Ç ´©µÎºÎ ÇùÂø¿¡ ÇÕº´ÇÏ´Â °æ¿ì°¡ ºñ±³Àû ¸¹´Ù. Áï Fallot 4ÁõÈÄÀÇ ÇÕº´ ±âÇüÀ¸·Î ³ªÅ¸³­´Ù. ÀÌ °æ¿ì ÁÂ¿ì Æóµ¿¸ÆÀÇ È®´ë, ¥±À½ Æóµ¿¸Æ ¼ººÐÀÇ ¿ÏÀü ¼Ò½Ç, ÇÇÄ¡°¡ ³·Àº È®Àå±â ÀâÀ½À» ³ªÅ¸³½´Ù. À̰ÍÀ» µ¿¹ÝÇÑ Fallot 4ÁõÈÄ´Â À¯¾Æ±â¿¡ ¿ïÇ÷¼º ½ÉºÎÀüÀ» ÀÏÀ¸Å°±â ½±´Ù.
  • absent testes syndrome
    °íȯ °á¿© ÁõÈıº
  • abstinence syndrome
    ±Ý´Ü ÁõÈıº
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
    1. ÇöÀúÇÑ ¸é¿ª °áÇ̰ú ÇÔ²² ±âȸ°¨¿°, ¼Ó¹ß¼º ¾Ï ¹× ½Å°æ°è Áõ¼¼°¡ µ¿¹Ý. ¹ÙÀÌ·¯½º ÀÚü¿¡ ÀÇÇÑ º´º¯°ú ¸é¿ª´É·Â ÀúÇÏ¿¡ µû¸¥ ±âȸ °¨¿° µîÀÇ ÀÌÂ÷Àû º´º¯ÀÇ µÎ °¡Áö·Î ´ëº°. HIV¿¡ ÀÇÇØ ¹ß»ýµÇ´Â ÁúȯÀ¸·Î ½Å°æ°è°¡ Áß¿ä Ç¥ÀûÁß Çϳª. ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ »ç¶÷ÀÇ 40% Á¤µµ°¡ Áúº´ÀÌ ¹ß»ý. ¹ÙÀÌ·¯½ºÀÇ Á÷Á¢ÀûÀÎ ¿µÇâ¿¡ ÀÌÇÑ º´º¯À¸·Î´Â ¸²ÇÁ±¸¼º ¼ö¸·¿°°ú HIV ³ú¿° µîÀÌ ÀÖÀ½. 2. ÈÄõ¼º ¸é¿ª°áÇÌÁõ. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
fibrinogen-fibrin conversion syndrome <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
analog-digital conversion The process of converting analog data such as continually measured voltage to discrete, digital form.
(12 Dec 1998)
bed conversion The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.
(12 Dec 1998)
biochemical conversion process The use of living organisms or their products to convert organic material to fuels.
(05 Dec 1998)
gene conversion <molecular biology> A phenomenon in which alleles are segregated in a 3:1 not 2:2 ratio in meiosis. May be a result of DNA polymerase switching templates and copying from the other homologous sequence or a result of mismatch repair (nucleotides being removed from one strand and replaced by repair synthesis using the other strand as template).
(18 Nov 1997)
plasmin prothrombins conversion factor <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
conversion An unconscious defense mechanism by which the anxiety that stems from intrapsychic conflict is converted and expressed in a symbolic somatic.
Origin: L. Con = with, versio = turning
(18 Nov 1997)
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
conversion electron An internal conversion electron.
(05 Mar 2000)
conversion hysteria Hysteria characterised by the substitution, through psychic transformation, of physical signs or symptoms for anxiety; generally restricted to such major symptoms as blindness, deafness, and paralysis, or lesser ones such as blurred vision and numbness.
Synonym: conversion hysteria neurosis, conversion neurosis, conversion reaction.
(05 Mar 2000)
conversion hysteria neurosis Hysteria characterised by the substitution, through psychic transformation, of physical signs or symptoms for anxiety; generally restricted to such major symptoms as blindness, deafness, and paralysis, or lesser ones such as blurred vision and numbness.
Synonym: conversion hysteria neurosis, conversion neurosis, conversion reaction.
(05 Mar 2000)
conversion neurosis Hysteria characterised by the substitution, through psychic transformation, of physical signs or symptoms for anxiety; generally restricted to such major symptoms as blindness, deafness, and paralysis, or lesser ones such as blurred vision and numbness.
Synonym: conversion hysteria neurosis, conversion neurosis, conversion reaction.
(05 Mar 2000)
conversion reaction A conversion of emotional stress or mental disturbance into a physical symptom.
Examples include paralysis, blindness, inability to speak or another sudden debilitating problem for no reason evident through testing.
(27 Sep 1997)
proserum prothrombin conversion accelerator A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs.
(12 Dec 1998)
serum prothrombin conversion accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
stand conversion The conversion of a noncommercial stand of timber to a commercial stand.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ; ÅÂȯ(ÅÂȯ)
  • conversion
    Àüȯ;ÀüÈ­(changing);(Áý.Â÷µîÀÇ)°³Àå;°³Á¶;º¯¼³;ÀüÇâ;°³Á¾;±ÍÀÇ (ƯÈ÷ ±âµ¶±³¿¡ÀÇ);(ÁÖ»ç¿Í ºó»ç¿ÍÀÇ)ȯÀ§(¹ý);(ºÎäÀÇ) Â÷ȯ;¹Ù²ãÁü;(ÁöÆóÀÇ)ÅÂȯ;(¿Ü±¹ÅëÈ­ÀÇ)ȯ»ê;ÀÌÀÚ¸¦ ¿ø±Ý¿¡ °¡»êÇϱâ;(Àç»êÀÇ)Àüȯ;(µ¿»êÀÇ)Ⱦ·É;Àüȯ(ÇÙ¿¬·á¹°ÁúÀÌ ´Ù¸¥ ÇÙ¿¬·á¹°Áú·Î º¯È­Çϱâ);~al;
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • conversion factor
    (¹®ÀÇ.ÀÚ·áû±¸¿¡¼­ ½ÇÁ¦ »óǰ±¸¸ÅÀÎÀ¸·ÎÀÇ)ÀüȯÀ²
  • conversion heater
    Àü¿­±â(electric heater)
  • conversion ratio
    Àüȯ ºñÀ²(Çٺп­½Ã ÇϳªÀÇ ¿øÀÚ¿¡¼­ »ý±â´Â ¿øÀÚÀÇ ¼ö
  • conversion table
    (µµ·®ÇüµîÀÇ)ȯ»êÇ¥
  • Down's syndrome
    ´Ù¿î ÁõÈıº(Mongolism)
  • HunterRussel syndrome
    ÇåÅÍ ·¯¼¿ ÁõÈıº(À¯±â ¼öÀº Áßµ¶)
  • Reye('s) syndrome
    ¶óÀÌ ÁõÈıº(¼Ò¾Æ¿¡°Ô ÈçÈ÷ ÀÖ´Â ³úÀå¾Ö)
  • behcets syndrome
    º£ÀÌú´(´«,ÀÔÀÇ Á¡¸·,À½ºÎ¿¡ º´ÀÌ »ý±è)
  • empty nest syndrome
    (Á¤ÀÇ)¼ºÀåÇÑ ÀڽĵéÀÌ ´Ù ¶°³ª¹ö¸° ³ë³â ºÎºÎ¿¡°Ô ÈçÈ÷ ³ªÅ¸³ª´Â ÁõÈıº(Á¤½ÅÀû ºÒ¾ÈÁ¤°ú ¿ì¿ïÁõÀ» ¼ö¹ÝÇÏ´Â ÇãÅ»°¨)
  • general adaptation syndrome
    ¹üÀûÀÀ ÁßÈıº
  • highpressure nervous syndrome
    °í¾Ð ½Å°æ ÁõÈıº
  • postvietnam syndrome
    º£Æ®³² ÈÄ ÁõÈıº
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á